Third Rock Ventures V, L.P.

Rapport Therapeutics, Inc. Common Stock · 10% Owner

Third Rock Ventures V, L.P. is listed in public filings as 10 percent owner. This Third Rock Ventures V, L.P. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Rapport Therapeutics, Inc. Common Stock (RAPP). Investors use Third Rock Ventures V, L.P.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Rapport Therapeutics, Inc. Common StockRAPP$252M6.3M sharesSellMay 26, 2026$743.8K18.6k shares$40.05--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Rapport Therapeutics, Inc. Common StockRAPP$254M6.3M sharesSellMay 11, 2026$5.4M133.6k shares$40.24--
Rapport Therapeutics, Inc. Common StockRAPP$259M6.4M sharesSellMay 8, 2026$202.3K5k shares$40.31--
Rapport Therapeutics, Inc. Common StockRAPP$258M6.4M sharesSellMay 7, 2026$10.9M271.5k shares$40.12--
Rapport Therapeutics, Inc. Common StockRAPP$270M6.7M sharesSellApr 17, 2026$17.2M426k shares$40.32--